Cargando…
Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial
OBJECTIVE: To evaluate the safety and efficacy of a 5 mg sublingual dose of zolpidem, compared to a 10 mg oral dose, at bedtime and “as needed” following middle-of-the-night awakenings. METHODS: Participants were randomized into an oral group (oral zolpidem 10 mg and sublingual placebo at bedtime an...
Autores principales: | Castro, Laura S., Otuyama, Leonardo J., Fumo-dos-Santos, Cristiane, Tufik, Sergio, Poyares, Dalva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Psiquiatria
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115453/ https://www.ncbi.nlm.nih.gov/pubmed/31859791 http://dx.doi.org/10.1590/1516-4446-2019-0389 |
Ejemplares similares
-
Insomnia and cardiovascular outcomes
por: Andersen, Monica L., et al.
Publicado: (2021) -
Is exercise an alternative treatment for chronic insomnia?
por: Passos, Giselle Soares, et al.
Publicado: (2012) -
Primary insomnia treated with Zolpidem in an 18-month-old child
por: Bhat, Tushar, et al.
Publicado: (2008) -
Zolpidem modified-release in insomnia
por: Kirkwood, Cynthia, et al.
Publicado: (2007) -
Chronotype and anxiety are associated in patients with chronic primary insomnia
por: Passos, Giselle S., et al.
Publicado: (2017)